PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $864,000 | -38.0% | 102,328 | 0.0% | 0.05% | +11.1% |
| Q1 2022 | $1,393,000 | -30.4% | 102,328 | +0.6% | 0.04% | -37.5% |
| Q4 2021 | $2,001,000 | +91.3% | 101,728 | +212.3% | 0.07% | +125.0% |
| Q3 2021 | $1,046,000 | -31.6% | 32,575 | -27.9% | 0.03% | -33.3% |
| Q2 2021 | $1,530,000 | -36.1% | 45,211 | -29.1% | 0.05% | -29.4% |
| Q1 2021 | $2,395,000 | +20.2% | 63,772 | +6.3% | 0.07% | -5.6% |
| Q4 2020 | $1,993,000 | – | 60,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |